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1. Introduction 
Photodynamic therapy (PDT) is an effective cancer treatment that is an alternative to local 
therapy including surgical treatment and radiotherapy or systemic treatment such as 
chemotherapy or some kinds of immunotherapy. In many patients with cancer these 
therapeutic methods are not efficient or put their life at serious risk. 
The principle of PDT is based on a photochemical process involving the absorption of light 
by a photosensitizer and the subsequent generation of reactive oxygen species (ROS) that 
induces cytotoxicity.  
In the body, photosensitizers accumulate particularly in cancer cells. The precise reason for 
this preferential uptake or retention by malignant tissue is still unclear, but properties that 
appear to be involved include activated cellular uptake by neoplastic cells, differences in 
proliferation rates between neoplastic and normal cells, leaky vasculature within neoplastic 
tissue, and variations in mitochondrial potential. Moreover, PDT is a selective treatment 
because light delivery can be restricted to specific regions, thereby limiting activation of the 
drug to cured areas. These conditions mean that PDT is a safe treatment in comparison with 
other local treatments such as ionizing radiation and thermal destruction of tissue.  
Oxygen-dependent photodynamic reactions were first described by Oscar Raab (Allison, 
2010). He noted that an acridine solution killed paramecia upon irradiation with light. There 
was no such effect observed in the absence of light. On the basis of this knowledge about 
photodynamic effects, H. Tappeiner and H. Jesionek performed the first PDT sessions on a 
patient with skin carcinoma, with eosin as a photosensitizer (Allison, 2010). Since that time 
PDT has made considerable progress; new photosensitizers have been discovered and the 
procedure of therapy has been established. 
1.1 Mechanism of action 
The procedure of PDT requires two steps: administration of a photosensitizer, and its 
activation by light in the presence of oxygen in the tissue. Photosensitizers used in PDT 
should be nontoxic in their native state, but after excitation they become cytotoxic and 
produce local tissue destruction through intercellular generation of ROS. The light induces 
excitation of the photosensitizer molecules to the singlet excited state, which can be 
converted into the triplet excited state. The triplet state may react with surrounding 
www.intechopen.com
 
Treatment of Metastatic Melanoma 
 
272 
molecules in two types of photo-oxidative reaction. Type I involves electron or hydrogen 
atom transfer, producing radical forms of the substrate which may react with oxygen to 
form peroxides, superoxide ions, and hydroxyl radicals. Type II leads to the generation of 
singlet molecular oxygen (1O2). Both mechanisms may occur simultaneously (Lukšienė, 
2003). It is known that 1O2 can diffuse only 20 nm during its lifetime (Peng, 1996); hence the 
primary damage is closely related to the site of its formation. Therefore, cellular structures 
having both a high sensitizer and a high oxygen concentration will be preferentially 
damaged upon illumination.  
In PDT also occurs a third type of reaction. In contrast to the other two it is independent on 
the dissolved oxygen in the tissue. In contrast to the other two it is independent of the 
dissolved oxygen in the tissue. The photosensitizer in the singlet excited state can react 
directly with biomolecules, inducing a process of photoadduct formation (Capella et al., 
2003). However, this mechanism is often ignored because the electron transfer between a 
biomolecule and photosensitizer, and formation of free radicals, is not effective (Ochneser 
1997).  
1.2 Photosensitizers in PDT 
The main features of an efficient photosensitizer are: low toxicity at therapeutic doses in 
darkness, highly tumor-targeting accumulation, homogeneous composition and stability, 
and absorption peaks in the low-loss transmission window of biological tissues (the far-red 
and near-infrared regions). An effective photosensitizer is characterized by a high quantum 
yield of singlet oxygen generation and/or electron transfer to substrate molecules 
(Granville, 2001, Lukšienė, 2003). Good photosensitizer qualities are high solubility in water, 
availability, uncomplicated manufacture and synthesis. 
Most photosensitizers applied in PDT are based on porphyrins. The most common 
photosensitizers are haematoporphyrin derivatives (HPD). Its theirs purified version named 
Photofrin, has an absorption peak in the red wavelength region at about 630 nm. The first 
compound in the porphyrin synthesis pathway (5-aminolevulinic acid, 5-ALA) is also used 
in PDT. 5-ALA is converted in vivo into the photosensitizing compound protoporphyrin IX. 
The second generation of photosensitizers includes compounds from other chemical groups. 
Most of them are cyclic tetrapyrroles consisting of substituted derivatives of porphyrin, 
chlorin and bacteriochlorin. Many research centers are developing new and quite different 
molecular structures that can act as the ideal photosensitizer (Granville, 2001).  
1.2.1 Light 
The photodynamic reaction is dependent on the delivery of light of an appropriate 
wavelength to activate a photosensitizer. The light used for photosensitization is typically in 
the visible or near-infrared light range. In general, with increasing wavelength in the visible 
and near-infrared range the depth of penetration of light increases and the absorption by 
hemoglobin and other endogenous chromophores decreases (Smith, 2002). 
Application in PDT of higher wavelengths of light enables treatment of heavily pigmented 
tissues (Woodburn, 1998). Good light sources in PDT are metal halogen lamps, which emit 
from 600 to 800 nm radiation at high power density, and short-arc xenon lamps, tunable 
over a bandwidth between 400 and 1200 nm (Lukšienė, 2003).  
The popularization of laser technology with optical fibers facilitates photosensitization in 
clinical treatment. Lasers enable the precise endoscopic application of light to almost every 
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site of the human body and allow the exact selection of wavelengths. Pulsed lasers, such as 
the gold vapor laser (GVL) and the copper vapor laser-pumped dye laser, produce brief 
light pulses of millisecond to nanosecond duration (Fisher 1995). Tunable solid-state lasers, 
such as the neodymium: YAG laser, are particularly useful for PDT. Portable semiconductor 
diode lasers, such as the gallium-aluminum-arsenide laser, produce light in the range from 
770 to 850 nm, which corresponds to the absorption peaks of many new photosensitizers 
(Lukšienė, 2003). 
2. Cell damage after PDT 
The antitumor activity of PDT is based on four mechanisms: direct cytotoxicity, which is an 
intermediate reaction of singlet oxygen production with subsequent oxidation of the 
substrate, occlusion of blood vessels and lymphatics, and the impact on the immune 
response and inflammation of the body (Krawczyk-Krupka et al., 2001, Sieron &Adamek, 
1999, Mazur et al., 2010). Generated reactive oxygen species (ROS) cause oxidative stress in 
the cells (Dellinger, 1996). The oxidative stress damage is targeted mainly at cellular 
macromolecules, such as lipids, nucleic acids and proteins. Hydrophobic photosensitizers 
accumulate mainly in cell membranes and they are primarily attacked by free radicals. 
2.1 Oxidative stress 
Oxidative stress is an imbalance between the formation of reactive oxygen species (ROS) 
and antioxidant mechanisms. Free radicals in living organisms may result from the action of 
endogenous factors (e.g. respiratory chain, activated leukocytes, inflammation, enzymes) or 
exogenous (e.g. cigarette smoke, alcohol, intense physical activity, UV radiation, ionizing 
radiation, car exhaust, contaminated air, physical and psychological stress). In physiological 
conditions the release of free radicals is controlled by the body's defense mechanisms (Sheu 
et al., 2006). Free radicals play a crucial role in cell functions including proliferation, 
apoptosis, inactivation of the growth of bacteria and viruses, intracellular signaling and 
intercellular communication. ROS have effects that augment or shrink the blood vessel 
walls, and stimulate glucose transport into cells. Disorder of the defense mechanisms under 
the influence of external factors or disease causes an increase in free radicals in the body, 
and consequently the occurrence of pathological reactions leading to damage to cells and 
tissues (Gałecka et al., 2008, Łagowska-Lenart et al., 2008). In vitro studies show that the 
destructive action of free radicals may include all biomolecules in the body, causing 
chemical modifications and damage to proteins (denaturation), lipids (peroxidation), 
carbohydrates and nucleotides, resulting in changes in the structure of DNA leading to 
mutations (Sheu et al., 2006, Bailey et al., 2005). The concentration of oxidation products (e.g. 
carbonyl groups) reflects the intensity of the reaction involving reactive oxygen species. An 
antioxidant barrier protects the organism from the damaging effects of reactive oxygen 
species.  
2.2 Lipid peroxidation 
Lipid peroxidation (LPO) is a free radical process of oxidation of polyunsaturated fatty acids 
or other lipids. Lipid peroxidation proceeds in three major steps: initiation, propagation, 
and termination. During the first stage a fatty acid radical is produced. The hydroxyl radical 
is identified as initiating lipid peroxidation by abstracting hydrogen atoms from fatty-acid 
side chains. Cell membranes contain unsaturated fatty acids that are readily attacked by 
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reactive oxygen species. LPO can be initiated by hydroxyl radical (OH), superoxide radical 
(LOO), alkoxy radical (LO), alkyl radical (L), as well as ozone (O3), nitrogen monoxide 
and dioxide, sulfur dioxides, and hypochlorite (Shevchuk et al., 2002, Bartosz, 2003).  
During the propagation phase, free alkyl radicals (L) react with molecular oxygen to form 
peroxyl free radicals (LOO). They may also detach hydrogen atoms from subsequent 
molecules of polyunsaturated fatty acids (LH). This cycle continues, as the new fatty acid 
radical reacts exactly in the same way until the termination reaction. The stage of 
termination occurs when a radical reacts with a non-radical. It is a “chain reaction 
mechanism” because a new radical is always produced. The radical reaction stops when 
there is such a high concentration of radical species that it can cause the impact of two 
radicals, forming a non-radical. 
The final products of lipid peroxidation are hydroxy aldehydes (e.g. 4-hydroxynonenal), 
hydrocarbons (e.g. ethane and pentane) and aldehydes (e.g. malonic dialdehyde – MDA) – 
an endogenous genotoxic compound (Bartosz, 2003, Kessel et al., 1997, Hsieh et al., 2003). 
Increased production of reactive oxygen species induces an increase of lipid peroxidation 
products. These LPO products are able to modify the physical properties of cell membranes, 
leading to a loss of integrity of intracellular membranes by depolarization, increased 
permeability to H- ions, disruption and inhibition of the activity of the asymmetry of 
membrane enzymes and transport proteins (Hsieh et al., 2003). 
2.3 Protein degradation under the influence of oxidative stress 
Oxidative changes are an inherent effect of cellular metabolism and can not be eliminated. 
Accumulation of oxidized protein products impairs cell functions and can even induce cell 
death (Plaetzer 2003). ROS can induce oxidation of protein thiol groups (-SH) and form thiol 
radicals (S˙). The most degenerating for the cell during oxidative stress is oxidation of thiols 
in the membrane. It can lead to membrane disintegration and increased permeability. 
Oxidative damage of –SH groups causes rapid loss of biological activity of protein. These 
radicals in turn oxidize to disulfides, forming intermolecular disulfide bridges. These 
reactions cause irreversible changes in membrane structures, which are dangerous to the life 
of the cell (Wang 2001). 
2.4 Changes in DNA 
DNA encodes genetic information, so any changes that occur in the genome are extremely 
dangerous for the cell. The number of daily incidents of DNA damage exceeds 10 000; 
therefore there are corrective mechanisms for sensing and correcting the damage. The 
mechanisms of DNA damage induced by photodynamic therapy are not well known. PDT 
can cause cross-linking of DNA strands (McNair et al., 1997, Haylett et al., 2003, Woods et 
al., 2004). DNA damage caused by photodynamic therapy may occur in cancer cells and 
normal cells surrounding the tumor. PDT generates through the photosensitizer reactive 
oxygen species. Singlet oxygen has a very limited range (< 0.1 μm) and life-span (less than 1 
s). The probability of DNA damage is low, unless it is generated in the close proximity of a 
DNA strand. Current studies suggest that cell death after PDT is caused by damage to 
cytoplasmic proteins and mitochondria, and not damage to DNA (Miller et al., 2007). 
Normal cells are able to cope with the damage after PDT but this is dependent on the type of 
photosensitizer (Woods et al., 2004). 
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2.5 Antioxidative system 
To protect against free radical damage the body uses a number of mechanisms to provide 
antioxidant protection of the body. Structural cell organization is one of these mechanisms. 
This specific formation enables isolation of those places where free radical reactions take 
place (Halliwell, 2000, Huang, 2000). In addition various metabolic mechanisms play an 
important role in protection against free radicals.  The knowledge of oxidative damage 
caused by PDT is important in developing strategies for treating tumours and the potential 
reduction of side effects. They have been divided into the following categories (Santiard, 
1995): 
- Reactions with suppressive compounds (carotenoids, vitamin E); 
- Non-enzymatic mechanisms: antioxidants, free radical scavengers, ions of transition 
metals, sequestration of metals, metallothioneins;  
- Enzymatic mechanisms: superoxide dismutase, catalases, heme oxygenase, glutathione 
peroxidase, glutathione reductase, glutathione S-transferase and groups of secretory 
phospholipases A2; 
- Reactions with heat shock proteins – proteases and chaperone proteins. 
2.5.1 MnSOD 
MnSOD is a mitochondrial form with Mn in the active center. Human MnSOD is a 
tetrameric enzyme with four identical subunits each harboring a Mn+3 atom (McCord, 2002). 
It was demonstrated that transient transfection with the MnSOD gene resulted in decreased 
effectiveness of PDT. These results suggest that MnSOD plays a leading role in the response 
to PDT and that abnormal mitochondria may be a decisive factor in phototoxicity (Saczko et 
al., 2007). MnSOD is a critical antioxidant enzyme residing in mitochondria. Golab et al. 
observed that following PDT there was induction of MnSOD expression in tumor cells 
(Golab et al., 2003). The group of SODs is emerging as significant antioxidative enzymes that 
can regulate the sensitivity of cancer cells to different treatment modalities. Some authors 
have also observed that overexpression of MnSOD suppresses apoptosis (Kuroda et al., 
2000).  
2.5.2 Heme oxygenase-1 (HO-1) 
Heme oxygenase exists in two isoforms: inducible (HO-1) and constitutively expressed (HO-
2). Heme oxygenase-1 (HO-1) is an enzyme that catalyzes the degradation of heme to Fe2+ 
ion, carbon monoxide and biliverdin, and then biliverdin is converted to bilirubin by 
biliverdin reductase (Dulak & Jozkowicz, 2003). Biliverdin and bilirubin are antioxidants, 
and may therefore play a very important role in cytoprotection of cells exposed to the 
oxidative stress induced by PDT. Induction of HO-1 by PDT was described in the CHO 
(Chinese hamster ovary) cell line using Photofrin (Gomer, 1991). The photodynamic reaction 
induces HO-1 expression. HO-1 also plays a protective role in cells where PDT was applied. 
The removal of iron ions with desferrioxamine from cells after PDT resulted in increased cell 
death, which confirms the key role of ferrous ion generation in HO-1 mediated 
cytoprotection (Nowis et al., 2006).  
2.5.3 Heat shock proteins  
The heat shock proteins (HSPs) are a class of proteins whose expression is increased when 
cells are exposed to different kinds of stress such as heat shock, pH shift, hypoxia, osmotic 
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and oxidative stress. Production of HSPs may also grow in response to infection, 
inflammation, effects of toxins, UV radiation, starvation, etc. HSPs work as chaperone 
proteins responsible for the proper folding of other proteins, translocation and degradation. 
They also participate in protein assembly, export, turnover and regulation. HSPs are found 
in virtually all living organisms. In normal conditions cellular levels of HSPs are stable and 
low, but if cells are exposed to any kind of stress, the levels of HSP quickly increase 
(Pockley, 2003). HSPs are generally classified according to their molecular weight, which can 
vary from 10 to 170 kDa, e.g. HSP70 (Hightower & Hendershot, 1997). PDT induces different 
HSPs including HSP27, HSP60, HSP70, HSP90, GRP78 and GRP94. A protective role in PDT-
treated cells has been shown, for example survival of tumor cells exposed to PDT induced 
overexpression of HSP27 (Wang et al., 2002). When there are damaged proteins, HSP binds 
damaged molecules. This results in dissociation of HSF (heat shock factor), then migrates to 
the nucleus, where it binds with HSE (heat shock elements) leading to HSP overexpression 
(Morimoto, 1993). HSP90 inhibits formation of an active apoptosome whereas HSP70 
prevents the recruitment of procaspase-9 to the apoptosome complex (Almeida et al., 2004).  
2.5.4 GSTπ 
Glutathione S-transferases (GSTs) are crucial in protection of cells against oxidation 
products. There are enzymes of the second phase of metabolism that counteract the process 
of carcinogenesis (L’Ecuyer 2004). This group of enzymes plays a key role in detoxification 
and reduction of reactive oxygen forms, especially the isoform GST-pi. This enzyme protects 
cells against DNA disintegration and drug toxicity. Genetic polymorphisms in glutathione 
S-transferase and its altered expression and activity are associated with oxidative DNA 
damage which in turn leads to increased susceptibility to cancer (L’Ecuyer al., 2004). A high 
level of GST-pi expression is related to the development of drug resistance in cancer cells 
not only by increased detoxification of anticancer agents, but also by suppression of cellular 
ROS which induce cell death. This means that a high level of GST-pi may be a prognostic 
factor in malignant diseases (Aliya et al., 2003).  
2.5.5 Small molecule antioxidants 
Molecular reactions of antioxidants with ROS are less specific than the effect of antioxidant 
enzymes, which means that these compounds are more versatile defenders. The body's 
antioxidant status is also dependent on the level of exogenous antioxidants, mainly supplied 
with food. An important role is played by vitamin E. Because of its lipophilic properties it 
may have a protective effect in relation to membrane phospholipids, protecting them from 
peroxidation. One free radical could trigger the whole cascade of reactions leading to 
oxidation of unsaturated fatty acids. This cascade proceeds until another formed fatty acid 
radical meets on their way vitamin E, which breaks the chain reaction. Reduced vitamin E 
can be regenerated by vitamin C that has the ability to stabilize the hydroxyl radical (Chow 
et al., 1999, Rahman, 2007, Sies et al., 1992). Vitamin C reacts with the hydroxyl radical and 
singlet oxygen. Vitamin C with glutathione coenzyme Q, cysteine, uric acid and bilirubin are 
among the active antioxidants in the aqueous phase. Vitamin C inhibits the peroxidation of 
hemoglobin and with coenzyme Q and reduced glutathione protects mitochondria from 
oxidative damage (Kurl et al., 2002). The effect of vitamin E supplements β-carotene and its 
metabolite, vitamin A. The precursors of vitamin A include carotenoids, the main dietary 
source of vitamin A in humans. In the gastrointestinal tract arises retinal, which is then 
converted to retinol (Rahman, 2007, Sies et al., 1992). 
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3. Mechanism of cell death 
Oxidative stress is a factor which initiates cell death after photodynamic reaction 
(Almmeida et al., 2004, Castano et al., 2005, Kulbacka et al., 2010, Saczko et al., 2009). In this 
part of our review we will examine the mechanisms of cell death caused by ROS and related 
metabolites, which are stimulated during the photodynamic process. The type of cell death 
by PDT may be mainly apoptosis or necrosis depending on the properties and concentration 
of the photosensitizer connected with the irradiation dose. However, another mode of cell 
death was also observed after photodynamic treatment, i.e. autophagic. This type II cell 
death is characterized by an enormous increase of two-membrane autophagic vacuoles in 
the cytoplasm which are finally catalyzed by lysosomal hydrolases (Edinger et al., 2004, 
Kroemer et al., 2005, Golstein et al., 2006). Autophagy is a convertible process, which can 
provoke both survival and death pathways, in contrast to the apoptotic irreversible process 
leading only to cell death (Kessel et al., 2007). Apoptosis (type I cell death) is genetically and 
morphologically different from necrosis. Apoptosis represents a regulated, universal and 
perfectly efficient, strongly controlled energetic suicide pathway. This process requires the 
activation of some hydrolytic enzymes – proteases and nucleases – leading to DNA 
fragmentation and destruction of cell structures. The morphological changes connected with 
apoptosis include nuclear pyknosis, DNA fragmentation, membrane blebbing, cell 
shrinkage and production of apoptotic bodies which are removed by adjacent cells and 
resident phagocytes (Kroemer et al., 1998 and 2005, Ryter et al., 2007, Kroemer et al., 2007). 
Apoptotic cell death is the most preferable effect of various anticancer therapies which leads 
to destruction and elimination of pathological cells. Inflammation does not occur through 
apoptosis in cancer cells and surroundings tissue (Fiers et al., 1999). On the other hand, 
necrosis (type III cell death) appears in a negative way as death associated with gross 
membrane damage and cell outflow into the extracellular space. This characteristic 
modification may lead to local inflammation and injury of nearby tissue. The endpoint of 
necrosis is manifested in cell swelling or oncosis (Majno et al., 1995). However, a recent 
study showed that necrosis can also occur similarly to programmed cell death, which 
consists of induction, commitment and execution processes of necrosis triggering the 
cysteine cathepsin-mediated lysosomal death pathway (Leist et al., 2001, Bizik et al., 2004, 
Golstein et al., 2005, Golstein et al., 2006). In general, it can be observed that lower doses of 
PDT lead to apoptosis, while higher doses lead to necrosis in cells (Ketabchi et al., 1998, 
Kessel et al., 2000). A previous study showed that the three well-known types of cell death 
are dependent on the developmental stage, physiological conditions of cells and the nature 
of the death signal (Majno 1995). Mixed-type cell death forms, containing characteristic 
properties for both types, apoptosis and necrosis, have been noted (Wang et al., 2003).  
3.1 Apoptosis following PDT 
The photodynamic reaction activates different signal transduction pathways connected with 
transcription factors and cell cycle regulation, which often lead to cell death or survival 
(Pazos et al., 2007, Robertson et al., 2009). The different types of cell death-induced 
photodynamic processes are permanently under investigation. However, the majority of 
studies have shown that apoptosis is a rapid and dominant type of cell death following the 
photodynamic reaction, in different experimental conditions and a variety of sensitizers 
(Oleinick et al., 2001). On the other hand, cancer cells can die in other ways: necrosis or 
autophagy (Buytaret et al., 2006). Autophagic and programmed necrosis are rarely related to 
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PDT. There are a few commonly known significant factors which can induce necrosis: extra-
mitochondrial location of photosensitizers, a high dose of PDT, and glucose starvation 
(Almeida et al., 2004, Kieslich et al., 2005, Nowis et al., 2005). Also the cells’ sensitivity to 
PDT conditions and their genotype may control the type of cell death following PDT (Wyld 
et al., 2001, Bar et al., 2007, Saczko et al., 2005). The most significant factors determining the 
effect of PDT are the physicochemical properties, intracellular distribution of 
photosensitizers, and the interactions between different cellular organelles such as 
mitochondria, lysosomes, endoplasmic reticulum (ER), Golgi apparatus and plasma 
membranes. The uptake of photosensitizers into cancer cells plays a decisive function in 
increasing the efficiency of PDT (Pazos et al., 2007, Robertson et al., 2009). Numerous studies 
with various first and second generation photosensitizers have concluded that the induction 
of apoptotic cell death by PDT was connected with mitochondrial damage (Kessel et al., 
1998, Saczko et al., 2005 and 2007, Chwiłkowska et al., 2006). Kessel and other researchers 
have demonstrated that sensitizers which localize in mitochondria are much more rapid 
inducers of apoptosis than photosensitizers localized in endoplasmic reticulum, Golgi 
apparatus, lysosomes and plasma membranes (Kessel et al., 1997, Dahle et al., 1990, Marchal 
et al., 2004). On the other hand, cationic photosensitizers or others accumulating in plasma 
membrane were associated with membrane photodamage and necrotic results (Kessel 1998, 
Luo 1996). Moreover, the availability of oxygen, the suitable wavelength and intensity of 
light, as well as the biological conditions and type of cancer cells can influence the mode of 
cell death (Rosa et al., 2000, Castano et al., 2004, Juzeniene et al., 2007, Plaetzer et al.,2003).   
Photodynamic therapy can induce apoptosis in two dissimilar pathways: intrinsic, 
mitochondria-dependent, and extrinsic, death receptor-dependent (Almeida et al., 2004).  
3.2 Intrinsic pathway 
Mitochondria play a crucial role in intrinsic pathways of apoptotic cell death, due to 
mitochondrial damage being the major object of photocytotoxicity. The mitochondrial 
pathway of apoptosis is often mediated when sensitizers are accumulated in these 
organelles, but it is not obligatory. The loss of mitochondrial transmembrane potential and 
the release of cytochrome c from the mitochondrial inner membrane space to the cytosol is a 
well-examined apoptotic occurrence, which has also been documented for numerous 
photosensitizers localized in mitochondria such as Photofrin, benzoporphin derivative, 
cyanine and phthalocyanine (Fabris et al., 2001, Pervaiz et al., 1999, Saczko et al., 2007). The 
present observation of apoptosis by the mitochondrial pathway shows that cytochrome c 
released to the cytoplasm forms a triple complex with the apoptosis-inducing factor (Apaf1) 
and procaspase 9, which leads to activation of procaspase 9 and following activation of 
executioner caspases. Uncontrolled generation of reactive oxygen species during PDT can 
lead to endoplasmic reticulum stress. It results in perturbation of the Ca2+ gradient, which 
can lead to the creation of a permeability transition complex and the involvement of Bcl-2 
proteins (Grebenova et al., 2003, Buytaret et al., 2006, Nowis et al., 2005). Some data show 
that the endoplasmic reticulum as well as mitochondria may induce apoptosis and 
autophagy in cancer cells following the photodynamic reaction. Manipulation of the PDT 
conditions results in suppression of apoptosis with increasing autophagy in mouse L1210 
leukemia cells (Kessel et al., 2007). The hydrophilic chlorine photosensitizers localize mainly 
in lysosomes and activate the mitochondrial apoptotic pathway following photodamage of 
lysosomes. The lysosomal proteases are released by lysosomal injury during the 
photodynamic reaction and activate caspases directly or indirectly through mitochondrial 
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damage. However, the mechanisms by which lysosome-localizing sensitizers induce 
mitochondrial apoptotic cell death are not fully elucidated (Nakajima et al., 1992, Mori et al., 
2000, Nagata et al., 2003, Reiners et al., 2002).  
3.3 Activation of caspases 
The apoptosis effectors contain intracellular proteases termed caspases. Caspases are a 
family of intracellular endopeptidases that are synthesized as zymogens and are converted 
into active enzymes. Caspases can be divided into two groups: initiators (numbers 1, 2, 4, 5, 
8, 9, 10 and 12) and effectors (numbers 3, 6 and 7) (Castano et al., 2005). The properties of 
apoptotic cell death are dependent on proteolytic cleavage of cellular substrates by effector 
caspases and can be activated by three dissimilar pathways involving intrinsic apoptosis 
activated by caspase 9, an extrinsic way connected with caspase 8, and an endoplasmic 
reticulum stress one induced by caspase 12. 
The mitochondrial pathway is associated with release of cytochrome c proteins by 
mitochondria into the cytoplasm involving establishment of caspase 9 and cleavage of 
executioner caspases 3, 6 or 7 (Ketabchi et al., 1998, Robertson et al., 2007). This leads to 
degradation of various proteins and DNA and finally cell death by apoptosis. Some 
investigations suggest that high doses of photodynamic therapy can photochemically 
inactivate crucial enzymes and other components of the apoptotic cascade such as caspases 
(Lavie et al., 1999). A previous study examined the level of expression of caspase 3, 8 and 9 
after photodynamic reaction with Photofrin® (Ph) using immunocytochemical assay (ABC 
method) in MCF-7 (human breast adenocarcinoma cell line) and A549 (human lung 
carcinoma cells). Differentiated expression of caspases 3, 8 and 9 in A549 cells was observed. 
The intensity of immunocytochemical staining of caspases depends on the concentration of 
Photofrin®, the time of irradiation and the incubation time after irradiation. Detection of two 
initiators, caspases 8 and 9, after photodynamic reaction in human lung adenocarcinoma 
A549 cells may suggest that apoptosis activation occurs by two independent signal 
transduction pathways, which are relative (Fabris et al., 2001, Grebenova et al., 2003, Saczko 
et al.,  2007). Also a mechanism has been documented in which caspase 8 cleaves Bid protein 
and there follows mitochondrial release of cytochrome c dependent activation of caspase 9 
(Buggiani et al., 2008). Moreover, a variety of apoptosis activation pathways induced during 
the photodynamic reaction can result in a lot of alternatives and cross-link the apoptotic 
signal transduction pathway (Almeida et al., 2004, Mitsunga et al., 2007). 
3.4 Bcl-2 family proteins and p53 status 
The Bcl-2 family proteins are divided into two groups: antiapoptotic Bcl-2, Bcl-Xl , and Bcl-
w, and proapoptotic Bax, Bak, Bad, and Bim, which respectively inhibit or support the 
execution of apoptotic cell death. Thus families of proteins control mitochondrial stability by 
maintaining the balance between proapoptotic proteins that translocate to the mitochondria 
and antiapoptotic ones that exist in the mitochondrial membrane (Ryter et al., 2007, Kelekar 
et al., 1998). The Bcl-2 gene product is located in the membranes of the endoplasmic 
reticulum, nuclear envelope and the external membranes of the mitochondria (Ryter et al., 
2007). The most significant objective of PDT in the cell signaling pathway is activation of the 
proapoptotic proteins belonging to the Bcl-2 family. Photodamage after photodynamic 
reaction provokes activation of these proteins and induces apoptosis in malignant cells. Bax 
protein expression has been linked to a beneficial reaction to PDT. It can be used to assess 
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the cancer response to photodynamic reaction (Zhen-hui Peng et al., 2008, Roland et al., 
2007, Robertson et al., 2007). Generally the role of Bax protein in the release of cytochrome c 
from mitochondria into the cytoplasm and activation of the apoptotic process has been 
established in many systems. Chiu and co-workers observed that phthalocyanine Pc-4-PDT 
induced Bax dislocation from the cytoplasm to mitochondria as early signaling for the 
mitochondrial pathway of apoptosis in human breast cancer MCF-7c3 cells (Chiu et al., 
2003). Phthalocyanine Pc4 is a new generation sensitizer that localizes in intracellular 
membranes, particularly in mitochondria. Pc4-PDT photodamages antiapoptotic Bcl-2 and 
Bcl-xL proteins and activates apoptosis in cancer cells (Castano et al., 2005, Kessel et al., 
2000, Xue et al., 2001). Usada et al. examined the cells with transfection and wild-type Bcl-2. 
Overexpression of Bcl-2 decreased apoptosis, which is connected with inhibition of the 
proapoptotic Bax protein. On the other hand, high doses of Pc4-PDT are necessary to 
activate Bax in cells with increasing expression of antiapoptotic Bcl-2 protein (Usada et al., 
2003). The p53 tumor suppressor gene takes part in the response to DNA damage, connected 
with cell cycle regulation, DNA repair, and induction of apoptosis (el-Deiry et al., 1998, 
Bunz et al., 1999). Expression of wild-type p53 activated by chemotherapy, radiation or 
photodynamic reaction increases the sensitivity to apoptosis, whereas mutated p53 
decreases the sensitivity. In many cases of cancer, mutated p53 was found (Lowe et al., 
1994). P53 plays a crucial role in regulation of proapoptotic Bcl-2 proteins. Bax induced the 
mitochondrial pathway by outflow of apoptogenic proteins, such as cytochrome c. 
However, in different studies the involvement of Bax and p53 in PDT-mediated apoptosis 
was observed (Fisher et al., 1997, Fisher et al., 1998, Zhang et al., 1999). Some data indicate 
that p53 is required for caspase 3 activation, suggesting that p53 may play a role in PDT-
activated early apoptosis in cancer cells (Mitsunga et al., 2007). Bar and co-workers 
examined the effect of Photofrin-PDT (Ph-PDT) on clear human ovarian carcinoma with a 
“silent” mutation in the p53 gene. The cells were dying in a necrotic way. They postulated 
that this mutation can inhibit apoptosis in these cells (Bar et al., 2007). The modification of 
Ph-PDT by 2-methoxyestradiol leads to activation of apoptotic cell death in these cells 
(unpublished data). Another study showed that PDT induced apoptosis in cancer cells 
independent on p53 (Almeida et al., 2004). 
3.5 Extrinsic apoptosis pathway 
This pathway is connected with initiation of the apoptotic process in response to induction 
of a cell surface receptor, such as the tumor-necrosis factor receptor (TNF-R) family of death 
receptor, or the apoptotic program can be initiated when a death ligand (Fas ligand – FasL) 
interacts with a cell surface receptor (Fas/APO-1/CD95) (Mupidi 2004). Death receptor 
mediated apoptosis occurs during photodynamic therapy when photosensitizers 
preferentially localize in the cell membrane. In human epidermoid carcinoma A431 treated 
photodynamic reaction with phthalocyanine 4 increasing levels of the surface death receptor 
Fas and of its ligand FasL were observed. Additionally, in the same conditions caspase-8 
cleavage was increased in Pc4-sensitized A431 cells. The function of the Fas/FasL system in 
PDT was also observed in canine kidney cells and hamster lung fibroblast after 
photosensitization with Photofrin (Almeida 2004). PDT-induced apoptosis is dependent on 
many metabolic signals which have an influence on the apoptotic pathway. Many 
examinations suggest that both the intrinsic and extrinsic pathway were crosslinked during 
photosensitization.    
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4. PDT in melanoma treatment  
Results from preclinical and clinical studies conducted worldwide over a 25-year period 
have established PDT as a useful treatment approach for some cancers (Mitton D, 2005). For 
more than 20 years scientists have maintained that PDT is not effective for pigmented 
melanomas (Ambrosone et al., 2005). Scientists focused on the improvement of inefficient 
PDT due to the competition between the absorbance of melanin from melanoma and the 
absorbance of photosensitizers at the photosensitizer excitation light wavelength. Melanin 
absorbs light over the entire wavelength region used for PDT (400-750 nm) (Ma et al., 2007). 
This was one reason why pigmented melanoma has been excluded in some PDT studies 
(Lim et al., 2004). It is well known that the longer wavelength of light absorption is, the 
deeper photosensitizer penetrates the skin (Woodburn et al., 1998). Since establishing the 
substantial heterogeneity of melanomas and their varying resistance to radio- and 
phototherapy, there have been intensive studies on the molecular processes occurring in 
these neoplasms during therapy (Kusmierz et al., 2009).  
The limitations of the porphyrin-derived photosensitizers with regard to light penetration 
into tissues promoted the synthesis of longer wavelength absorbing photosensitizers 
(Kreimer- Birnbaum, 1989). PDT treatment with lutetium texaphyrin (PCI-0123) (excitation 
at 732 nm) promoted survival of mice bearing the highly pigmented B16F10 melanoma 
(Woodburn et al., 1998). Also in these studies tumor apoptosis was evident in the PDT-
treated neoplasms after irradiation. PDT is a process with membranes being a principal 
target (Henderson et al., 1992). Woodburn et al. performed a confocal laser scanning 
microscopy studies with PDT and PCI-0123. Thre was proved that PDT destroys the 
melanosomal membrane, which leads to death due to oxidative stress of cells (Woodburn et 
al., 1997 and 1998). 
An important aspect of the antitumour effectiveness of PDT is related to the distribution of 
the photosensitizer. The localization of the drug in cytoplasmic organelles during PDT plays 
a major role in cell death (Saczko et al., 2007). It was suggested that localization of 
photosensitizing drugs in the plasma membrane, or in lysosomes, leads to necrosis after 
PDT treatment. Localization in the mitochondrial membrane causes apoptosis (Chen et al., 
2000). Intracellular accumulation of the photosensitizing drug is one of the most important 
factors to determine the efficacy of PDT (Saczko et al., 2007; Lam et al., 2001; Ogura et al., 
2003). Photofrin (Ph) was the first photosensitizer used in PDT of cancer. This drug has 
proved to be effective in the treatment of many cancers (Almeida et al., 2004). Ph has been 
involved in several mechanisms in PDT, such as cytotoxicity and apoptosis (Konan et al., 
2002). Saczko et al. showed that the intracellular localization of Ph in a cultured malignant 
melanoma (Me45) cell line is mainly intracellular compartments and mitochondrial 
membranes (Saczko et al., 2007). Ricchelli et al. also reported that Ph was localized in the 
mitochondria in vitro (Ricchelli et al., 1990). Mitochondria play an important role in the early 
events of apoptosis (Lam et al., 2001; Patito et al., 2001). Marchetti et al. demonstrated that 
Ph is a ligand for the mitochondrial peripheral benzodiazepine receptor, which is 
responsible for triggering pore transition (Saczko et al., 2007, Marchetti et al., 1996).  
The mitochondrial apoptotic pathway was also shown by Chen et al. in therapy with 
methylene blue (MB) (Chen et al., 2008). It is a photosensitizer which has excellent 
photochemical properties. MB is well known to have a high quantum yield of intersystem 
crossing and singlet oxygen generation and can produce radical species in the presence of 
reducing agents (Gabrielli et al., 2004; Tardivo et al., 2005). This photosensitizing drug has 
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affinity for melanocyte-produced melanin, which contributes to selective absorption of this 
compound by cutaneous melanomas (Link et al., 1989). MB showed enhanced penetration 
efficiency into melanoma cells and also in mitochondrial membranes, which induced 
apoptotic cell death by causing mitochondrial dysfunction (Ball et al., 1998). Chen et al. 
showed that MB-PDT could induce apoptotic cell death through the photochemical 
generation of reactive oxygen species that activate the caspase-9 and caspase-3 apoptosis 
pathway (Chen et al., 2008). A transplantable mouse melanoma model showed that the 
tumor size in treated mice decreased, which was associated with enhanced apoptotic cell 
death.  
Nowak-Sliwinska et al. have tested several photosensitizers to evaluate their photoefficiency 
in the Cloudman S91/I3 mouse melanoma cell line (Nowak-Sliwinska et al., 2006). They 
compared the efficiency of the photodynamic effect using cyanine (MC540) and porphyrin 
derivative photosensitizers (Photofrin and verteporfin). Their study showed that verteporfin 
and Photofrin are effective compounds with the classical type II mechanism of 
photodynamic reaction, but verteporfin is the most potent photosensitizer against 
melanoma cells. Generation of singlet molecular oxygen by photo-activated verteporfin was 
more than twice as high as in the case of Photofrin. The LD50 light dose for verteporfin was 
four times lower than for Photofrin, in spite of the much lower concentration used (2 vs. 10 
lg/ml) and 10 times higher for MC540 than for Photofrin. Busetti et al. described the 
pharmacokinetics of verteporfin in mice and showed that a single treatment inhibited 
growth of B16 tumor (Busetti et al., 1999). 
Induction of apoptosis by PDT seemed to play an important role in the photodynamic 
treatment efficacy (Barge et al., 2004). Ph-PDT induces cell death in the human Beidegröm 
Melanoma (BM) cell line mainly through apoptosis (Saczko et al., 2005). The application of 
comet assay to study the influence of Ph-PDT on BM cells showed that some types of DNA 
damage depend on photosensitizer concentration, as well as on time and dose of irradiation. 
Similar results were obtained by Barge et al. (Barge et al., 2004) in human melanoma cells 
using a new silicon phthalocyanine photosensitizer and by Haddad et al. in murine 
malignant melanoma in vitro and in vivo using aluminum phthalocyanine (AlpcS4) (Haddad 
et al., 1998) 
Higher doses of light and sensitizer lead to a dose-dependent augmentation of reaction 
oxygen species in melanoma cells (Kästle et al., 2011; Kolarova et al., 2007). A widely used 
photosensitizer is the protoporphyrin IX (PpIX) precursor 5-aminolevulinic acid (ALA). 
ALA is the first molecule in heme biosynthesis which is converted to the active 
photosensitizer PpIX in the mitochondria. Kästle et al. showed that WM451LU cells are 
more affected by ALA-PDT than non-tumorigenic keratinocytes (Kästle et al., 2011). The 
reason for this is elevated porphobilinogen deaminase activity and a significant decrease in 
ferrochelatase activity in cancer cells (Dailey et al., 1984; Kästle et al., 2011; Leibovici et al., 
1988). What is more, PDT of melanoma with porphyrin and porphyrin derivatives is 
effective and well tolerated by patients (Szurko et al., 2003). 
Kolarova et al. studied the effects of zinc-5,10,15,20-tetrakis(4-sulfonatophenyl) porphyrin 
(ZnTPPS4) on human G361 melanoma cell line (Kolarova et al., 2005). Analysis of DNA 
damage in the cell line after PDT was proved by comet assay. This treatment method gave 
rise to DNA damage. Further studies demonstrated that ZnTPPS4 induces the highest ROS 
production in the G361 cell line compared to other porphyrins - TPPS4 and PdTPPS4. A 
correlation was observed between ROS production and cell survival. The results 
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demonstrate that the photodynamic effect depends on sensitizer type, its concentration and 
light dose (Kolarova et al., 2007). Later research showed the most significant phototoxic 
effect of chloraluminium phthalocyanine disulfonate (ClAlPcS2)-PDT in spite of significantly 
higher ROS production induced by ZnTPPS4–PDT on G361 cells (Krestyn et al., 2010). 
HO-1 has a number of potential protective effects against oxidative stress. Additionally, the 
last catalytic product of HO-1 is CO. CO acts as a second messenger. It has anti-
inflammatory and anti-apoptotic effects (Bilban et al., 2008). Its expression is closely related 
to the oxidative stress levels in the cells (Saczko et al., 2007). An increase in expression of 
HO-1 following photodynamic therapy was observed by Gomer et al. (1991) and Nowis et 
al. (2006). They demonstrated that overexpression of HO-1 protects cancer cells against PDT 
with Photofrin. Other authors have also reported that PDT with 5-ALA resulted in increased 
formation of ROS and further enhancement of HO-1 induction (Frank et al., 2007). Kästle et 
al. applied inhibitors of HO-1 and PARP what improved the efficiency of photodynamic 
treatment (Kästle et al., 2011). Drastic reduction in viability by the addition of ZnPpIX is 
among other things the result of higher ROS levels (75% more than without ZnPpIX) after 
irradiation and inhibition of HO-I (Kästle et al., 2011). Also inhibition of the protein PARP-1 
seems to be a plausible addition to anticancer treatment. PARP is a protein involved in a 
number of cellular processes. One of its important functions is to assist in the repair of 
single-strand DNA breaks. If one single-strand broken DNA is reduplicated, a double-
strand broken DNA results. If PARP is inhibited, cell death occurs (D'Amours et al., 1999). 
In the co-culture 65% of WM451LU melanoma cells and 35% of HaCaT keratinocytes were 
present before PDT. After PDT the proportion was 41% of melanoma cells and 59% of 
HaCaT cells. Combination of both inhibitors with PDT improves these results to 16% of 
melanoma cells and 84% of HaCaT cells. Addition of HO-1 and PARP inhibitors 
significantly improves the efficiency of photodynamic treatment (Kästle et al., 2011). 
A very interesting study was presented by Ma et al. (2007). In that work reflectance 
spectroscopy was applied to study depigmentation of human and murine skin with 
different melanin contents, and effects induced by PDT with topical application of methyl 5-
aminolevulinate (MAL) on B16F10 melanotic melanomas transplanted to mice. Skin 
depigmentation leads to increase in reflectance. PDT with violet light (420 nm) bleached 
some of the melanin in the skin above the B16F10 melanomas. It was concluded that violet 
light in PDT can bleach melanin in melanotic tumors and therefore increase their sensitivity 
to red light (634 nm). This finding indicates a new PDT modality (Ma et al., 2007). 
The direct effects of PDT are cytotoxic for cancer cells, but it also could induce an immune 
system response, what has been proved in vitro (Blom et al., 1997). Treatment of ocular 
melanoma cells with hematoporphyrin ester (HPE)-PDT temporally alters the expression of 
HLA class I and β2-microglobulin. This may affect anti-tumor-immune responses. 
5. Conclusions 
Photodynamic therapy, a minimally invasive therapeutic modality, has been shown to be 
effective in a number of oncological and non-oncological conditions. The advantages of PDT 
application are better cosmetic outcomes without surgical scars or the discoloration that is 
evident in surgery or cryotherapy. Moreover, PDT may be used to decrease the size of a 
large tumor, which can be subsequently removed with a smaller excision. The experience in 
the use of PDT in the treatment of other skin diseases, including psoriasis, sarcoidosis, acne 
and human papillomavirus infections, is preliminary and undergoing clinical testing. 
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Although the idea of PDT usage is rather simple, the procedure is complicated by several 
parameters such as the formulation of the photosensitizing agents, the mode of delivery and 
duration of application, as well as the multiple light-specific parameters, such as exact 
wavelength, duration and intensity of various light sources. With the application of second-
generation, stable, lipophilic photosensitizers with optimized wavelengths, PDT may be a 
promising tool for therapy in skin cancer. Melanoma is the most severe of all skin neoplasms 
as it may grow rapidly and metastasize. For many years melanoma, mainly due to the 
presence of melanotic biopolymers and the presence of gene mutations which code pro-
apoptotic proteins, has been included in the group of resistant irradiation cancers. However, 
the research in recent years has indicated high variation in sensitivity in melanoma cells. 
This information has led many researchers to focus on examining the potential use of 
photodynamic therapy (PDT) in the fight against this cancer. The application of 
photodynamic therapy opens new perspectives in treatment of this tumor. Photodynamic 
therapy is an effective local cancer treatment that induces cytotoxicity through intercellular 
generation of reactive oxygen species. There are three indispensable components in this 
therapy: a photosensitizer, light, and oxygen inside the diseased tissue. The photosensitizer 
is accumulated in the target cells and absorbs light of certain wavelength. The energy is 
transferred to oxygen and highly reactive oxygen species are generated. This is usually 
singlet oxygen. Potential cellular targets for photodynamic therapy are the cell membrane 
and membranous organelles such as mitochondria, lysosome and nuclei. The disintegration 
of cellular structures and modulation of genetic information induced by PDT leads cancer 
cells to a death pathway. Numerous studies suggest that the exposure of tumor cells to PDT 
can lead to cell death via two separate processes: apoptosis and necrosis. In contrast to 
necrosis, apoptosis is an energy-dependent, distinct form of cell death that follows a 
sequence of genetically programmed events and proceeds without inflammation.  Morover 
there was also noticed that photodynamic therapy can increase the radical and the oxidant 
processes in oncological patients whose antioxidative mechanisms are overworked. 
Potential targets for PDT in melanoma eradication include cell proliferation inhibition, 
activation of cell death, reduction in pro-survival autophagy and a decrease in the cellular 
melanocytic antioxidant system. As we have indicated, more research on PDT with 
melanoma is needed to determine the exact parameters optimal for the treatment of this 
disease. In our opinion PDT should be considered as a good candidate for treatment in 
malignant melanoma. This technique may be also a promising device for melanoma in 
combation with standard therapies.  
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Surgery continues to be the mainstay treatment for melanoma localized to the primary tumor and/or lymph
nodes. Results from randomized controlled trials indicate that sentinel node biopsy for the treatment of
cutaneous melanoma of intermediate thickness has a beneficial effect on recurrence rates, and adjuvant
radiotherapy to regional lymph node fields following surgical resection reduces loco-regional recurrence in
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continue to be evaluated for treatment of stage IV disease. However, the greatest excitement in new treatment
has been with targeted therapies for genetic mutations. In particular, the promising results of partial and
complete tumor response in stage IV disease from early phase trials of the B-RAF kinase inhibitors. This book
provides a contemporary insight into the therapeutic treatment options for patients with metastatic melanoma
and is relevant to clinicians and researchers worldwide. In addition, an update on current clinical trials for
melanoma treatment has been included, and two chapters have been reserved to discuss the treatment of oral
and uveal melanoma.
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